Danircap 125 contains the main active ingredient Cefdinir, a semi-synthetic antibiotic belonging to the 3rd generation cephalosporin group. The mechanism of action of Danircap is inhibition of bacterial cell wall synthesis. Danircap is indicated in the treatment of many types of infections such as pharyngitis, tonsillitis, otitis media, pneumonia, bronchitis, ...

Danircap 300mg is an antibiotic used to treat mild to moderate infections caused by susceptible bacteria. The drug is prepared in the form of hard capsules, box of 1 blister x 4 tablets. Before using the drug Danircap 300, patients need to understand the use, consult a doctor to know the dose and unwanted effects.